FOXP3 and neoplasm: When we combined our markers, patients showing the worst prognosis were patients with tumors bearing 2 or 3 negative prognostic markers; patients with loss of HLA class I tumor expression, weak HLA-G tumor expression and low tumor infiltration with Foxp3+ cells.